Prescreening of Natural Products in Drug Discovery Using Recombinant Bioluminescent Bacteria
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Eui Jong | - |
dc.contributor.author | Seo, Ho Bin | - |
dc.contributor.author | Gu, Man Bock | - |
dc.date.accessioned | 2021-09-01T20:00:13Z | - |
dc.date.available | 2021-09-01T20:00:13Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 1226-8372 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/67801 | - |
dc.description.abstract | Strains of recombinant bioluminescent bacteria (RBB) which respond to toxic environments using various stress promoters are practical means of assessing toxicity. In previous research, RBB has proven useful for highthroughput screening in the drug development process. The goal of this research is to demonstrate that RBB can also be used for the toxicity screening of natural products. The RBB strains used were DPD2511, BBTSbmC, TV1061, and GC2, which were selected to respond to oxidative stress, DNA damage, protein damage, and cellular toxicity, respectively. The test drugs (paclitaxel, etoposide, and pentostatin) were carefully selected because these drugs needed to be natural products or their derivatives whose cellular toxicity had previously been reported from human cell line assays. After treating the RBB strains with various doses of the chosen drugs, their bioluminescent signals were measured over time. The effectiveness of the RBB method was proven by comparing its results to existing toxicity data for the selected drugs. In addition, a similar test using podophyllotoxin, a precursor of etoposide, and a derivative of podophyllotoxin, teniposide, was conducted to prove that the RBB method is suitable for a comparative analysis of toxicity among chemicals with similar molecular structures. As a detection method, RBB bacteria provide a much easier and more rapid culturing process compared to conventional human cell line assays. Because the implementation of the RBB method in the drug discovery process would enable efficient prescreening, a significant reduction in time, effort, and development costs are expected. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING | - |
dc.subject | ESCHERICHIA-COLI | - |
dc.subject | ETOPOSIDE | - |
dc.subject | TOXICITY | - |
dc.subject | CLASSIFICATION | - |
dc.subject | INDUCTION | - |
dc.subject | LEUKEMIA | - |
dc.subject | CANCER | - |
dc.subject | GENES | - |
dc.title | Prescreening of Natural Products in Drug Discovery Using Recombinant Bioluminescent Bacteria | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Gu, Man Bock | - |
dc.identifier.doi | 10.1007/s12257-018-0384-4 | - |
dc.identifier.scopusid | 2-s2.0-85062940168 | - |
dc.identifier.wosid | 000461396500030 | - |
dc.identifier.bibliographicCitation | BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, v.24, no.1, pp.264 - 271 | - |
dc.relation.isPartOf | BIOTECHNOLOGY AND BIOPROCESS ENGINEERING | - |
dc.citation.title | BIOTECHNOLOGY AND BIOPROCESS ENGINEERING | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 264 | - |
dc.citation.endPage | 271 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002467120 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | ETOPOSIDE | - |
dc.subject.keywordPlus | TOXICITY | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | LEUKEMIA | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | GENES | - |
dc.subject.keywordAuthor | recombinant bioluminescent bacteria (RBB) | - |
dc.subject.keywordAuthor | drug discovery | - |
dc.subject.keywordAuthor | natural products | - |
dc.subject.keywordAuthor | prescreening | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.